Chinese biotech LTZ Therapeutics has closed an oversubscribed series A+ financing round, raising $40 million to support its ...

A new analysis by Charles River Associates, commissioned by European industry group EFPIA, suggests that a proposed reward ...

UK-listed medtech Convatec Group (LSE: CTEC) plans to launch its new wound care technology, ConvaNiox (nitric oxide), later ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

California-based biotech Halozyme Therapeutics (Nasdaq: HALO) yesterday revealed it has filed a patent infringement lawsuit ...

US biotech Equillium’s (Nasdaq EQ) shares fell by 3% to $0.47 after the company announced that the US Food and Drug ...

Gilead Sciences (Nasdaq: GILD) reported flat revenues for the first quarter of 2025, with total sales reaching $6.7 billion, ...

Swiss-American biotech Granite Bio has exited stealth mode with $100 million in funding and plans to advance two experimental ...

The US Food and Drug Administration (FDA) approved penpulimab-kcqx, from little known Chinese biotech Akeso Biopharma (HKEX: ...

Misalignment doesn't usually announce itself. It tends to show up quietly—when teams are making different assumptions, when ...

Dutch biotech Avidicure has launched with $50 million in seed financing to support development of a novel class of ...

South Korea’s Samsung Bioepis today released its Second Quarter 2025 Biosimilar Market Report, which provides the second ...